Ipsen, Inc

1 similar search for Ipsen, Inc

Ipsen, Inc.

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

399 documents for Ipsen, Inc

- Ipsen Inc.
Jake Hamid has been appointed to the position of chief operating officer of Ipsen Inc., Rockford, Ill. [ILLUSTRATION OMITTED] ...
- Modern Casting
- Vol. 100 Nbr. 6, June 2010
- Admin of the Tulane Educ Fund, et al v. Biomeasure, (5th Cir. 2011)
...v. IPSEN, S.A.; IPSEN PHARMA SAS, formerly named Societe de...
- Federal Circuits
- Ipsen Inc.
Ipsen Inc., Cherry Valley, Ill., has hired Andrew Yazot as a direct international sales engineer. ...
- Modern Casting
- Vol. 99 Nbr. 11, November 2009

- Ipsen Completes the Acquisition of Tercica, Inc. in North America, the Third of Its Three Steps to Globalize Its Fast Growing Specialist Care Business.
PARIS -- Regulatory News: Ipsen (Paris:IPN) announced today that stockholders of Tercica, Inc. (Nasdaq:TRCA) voted to approve its previously announc...
- Business Wire
- October 17, 2008
- Ipsen Inc.
Ipsen Inc., Rockford, Ill, hired Bill St. Thomas as its sales manager for North America. ...
- Modern Casting
- Vol. 99 Nbr. 2, February 2009
- Coffee Break / Gtx Ends Drug Deal with Ipsen
Memphis-based GTx Inc. said Wednesday it is ending a development deal with drug maker Ipsen Ltd. over the bone drug toremifene. The drug is designed to reduce bone fractures in men who have prostate cancer and are being treated with androgen deprivation therapy, which can weaken bones. In 2009, the FDA asked for more information on the drug before considering it for approval. The company said it would have to conduct an additional study to have the drug application reviewed.
- The Commercial Appeal (2007-Current)
- March 03, 2011
- Current and future botulinum neurotoxin type A preparations in aesthetics: a literature review.
... Inc., Irvine, CA; Dysport Cosmetic [R], Ipsen Ltd, Berkshire, UK which is marketed by Galderma i...
- Journal of Drugs in Dermatology
- Vol. 9 Nbr. 9, September 2010
- Gtx, Ipsen Strike Toremifene Deal -- Partnership Bolstered On Bone Drug Program
GTx Inc. and Ipsen have strengthened their partnership in a $58 million deal to push along the bone drug program that failed to get approval from the Food and Drug Administration late last year. Paris -based Ipsen will pay Memphis-based GTx about $58 million in milestone payments upon the initiation, enrollment and progression of a second late-stage trial of the 80 milligram dose of toremifene.
- The Commercial Appeal (2007-Current)
- March 24, 2010
- Ipsen's Half-year 2010 Results.
Dynamic drug sales of [euro]538 million, up 6.0% year-on-year at constant currency Strong growth of Specialty care products, up 14.4% year on year a...
- Business Wire
- August 31, 2010
- EduLink, Inc. Announces Appointment of Eric Ipsen as Vice President, Business Development and Sales.
Business Editors/Hi-Tech Writers BEVERLY HILLS, Calif.--(BUSINESS WIRE)--Aug. 30, 2001 EduLink, Inc. (OTCBB:MYIQ) (d/b/a The Learning Priority) an...
- Business Wire
- August 30, 2001